The global precision medicine market is expected to grow at a CAGR of 12.48 % during the period 2015 to 2022.
Precision medicine is medicines developed on the basis of information derived from an individual’s genetic profile that helps as a guide for the prevention, diagnosis and treatment of diseases. It involves sequencing the individual genetic makeup and then using that information for the treatment, prevention and mitigation of diseases. The sequencing of the human genome forms the basis of precision medicine. Personal healthcare, integration of wireless technologies with portable healthcare devices, and increase in genetic diseases (due to mutation, UV rays) among others are the major market driving factor for precision medicine. However there remains some constraints such as potential threat to personal data, high diagnostic cost as a barrier, potential risk of hardware or software failure, stringent regulations and standards, lack of awareness about the possible applications of precision medicine, reimbursement policies and regulatory framework, limited knowledge about the application of test and techniques, lack of research and evidences creating hindrances in its application.
Test the market data and market information presented through more than 60 market data tables and figures spread over 80 numbers of pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Global Precision Medicine Market Research Report – Forecast to 2022”.
Global Precision Medicine Market:
The global precision medicine market is a new avenue and has immense potential and is expected to grow with an impressive CAGR of 12.48 % during the forecasted period.
- Abbott Laboratories,
- Almac Group, Ltd.,
- Asuragen, Inc.,
- Biomérieux Sa,
- Cepheid Inc.,
- Cetics Healthcare Technologies Gmbh,
- Ge Healthcare,
- Glaxosmithkline Plc,
- Johnson & Johnson,
Laboratory Corporation Of America Holdings, Medtronic, Novartis, Pfizer Inc., Qiagen, Biobase Gmbh, Quest Diagnostics Inc, Randox Laboratories Ltd., Sanofi Pharma, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Ab-Biotics Sa, Caris Life Sciences, Healthcore, Inc., Ibm, Innventis, Intel Corporation, Molecular Health Gmbh, Precision For Medicine and others.
Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/925
Depending on geographic region, precision medicine market is segmented into four key regions: Americas, Europe, Asia Pacific, and Middle East & Africa. Globally developed countries led by North America are the largest market for Precision medicines. Europe is the second-largest market for Precision medicines. The developed region will lose the lead to the developing in the nearest future.
Global precision medicines market has been segmented on the basis of ecosystem (pharma & biotech companies, diagnostic tool companies, healthcare it/ big data companies, clinical laboratories), by sub-markets (companion diagnostics, biomarker-based test, targeted therapeutics, pharmacogenomics, molecular diagnostics, others), and by therapeutics (cancer/oncology, cardiovascular disease, central nervous system, infectious diseases, others)
Access Report Details @ https://www.marketresearchfuture.com/reports/precision-medicine-market
Table of Content
1 Report Scope
1.1 Scope Of The Study
1.2 Precision Medicine: Report Coverage
1.3 Research Methodology
1.3.1 Research Methodology For The Global Market Study
18.104.22.168 Geographical Analysis
22.214.171.124 Demand Side & Supply Side Analysis
126.96.36.199 Data Synthesis And Bridging
1.3.2 Global Precision Medicine: Research Methodology
1.3.3 Key Data Point Sources
188.8.131.52 Data Points Taken From Secondary Sources
184.108.40.206 Data Points Taken From Primary Sources
1.4 Report Description
List of Figures
Figure 1 Precision Medicine Market Study
Figure 2 Research Methodology
Figure 3 Different Phases Of Research Methodology For The Global Market
Figure 4 Precision Medicine Market: Research Methodology
Figure 5 Global Precision Medicine Market Share, By Ecosystem, 2014-2022 ($Billion)
Browse Related Statistical Report
Europe Clinical Reference Laboratory Market, is projected to grow at a CAGR of 5.4% and is expected to reach US$ 1,14,128.8 million by 2027. In Europe Clinical Reference Laboratory Market, Western Europe accounted for the largest market share in 2016.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Name: Akash Anand
Organization: Market Research Future
Address: Market Research Future Office No. 524/528,
Phone: +1 646 845 9312